Epigenetic therapy targeting bone marrow mesenchymal stem cells for age-related bone diseases
Abstract As global aging accelerates, the prevention and treatment of age-related bone diseases are becoming a critical issue. In the process of senescence, bone marrow mesenchymal stem cells (BMSCs) gradually lose the capability of self-renewal and functional differentiation, resulting in impairmen...
Main Authors: | Yi Zhao, Jiawei He, Tao Qiu, Haoyu Zhang, Li Liao, Xiaoxia Su |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-022-02852-w |
Similar Items
-
Epigenetic regulation of mesenchymal stem cell aging through histone modifications
by: Yanping Sun, et al.
Published: (2023-11-01) -
Epigenetic control of mesenchymal stem cells orchestrates bone regeneration
by: Xiaofeng Wang, et al.
Published: (2023-03-01) -
Biohybrid Bovine Bone Matrix for Controlled Release of Mesenchymal Stem/Stromal Cell Lyosecretome: A Device for Bone Regeneration
by: Elia Bari, et al.
Published: (2021-04-01) -
Inflammatory Microenvironment Accelerates Bone Marrow Mesenchymal Stem Cell Aging
by: Xin Peng, et al.
Published: (2022-05-01) -
Adipose, Bone Marrow and Synovial Joint-derived Mesenchymal Stem Cells for Cartilage Repair
by: Christopher Fellows, et al.
Published: (2016-12-01)